What is it about?
The aim of this study was to prepare and characterize oral delivery of morin hydrate-loaded micellar nanocarriers using Pluronic P127 and Pluronic F123 for the effective management of Alzheimer’s disease.
Featured Image
Why is it important?
After administration of formulation brain and blood drug concentration were found to be highest for optimized morin hydrate-loaded micellar nanocarriers as compared to plain morin hydrate. Significant (p<0.05) reduction in assessed pharmacodynamic parameters was observed after administration of morin hydrate-loaded micellar nanocarriers as compared to disease control group. Chronic treatment with morin-loaded micelles significantly increased the memory in AlCl3 induced Alzheimer’s disease in Wistar rats.
Perspectives
Worth Reading it.
Amit Sharma
Uttarakhand Technical University, Dehradun and ISF College of Pharmacy, Moga
Read the Original
This page is a summary of: Development and characterization of morin hydrate-loaded micellar nanocarriers for the effective management of Alzheimer’s disease, Journal of Microencapsulation, February 2018, Taylor & Francis,
DOI: 10.1080/02652048.2018.1441916.
You can read the full text:
Contributors
The following have contributed to this page
